Schmidt, Kevin
Schmidt, Arne
Groß, Sonja
Just, Annette
Pfanne, Angelika
Fuchs, Maximilian
Jordan, Maria
Mohr, Elisa
Pich, Andreas
Fiedler, Jan
Thum, Thomas
Funding for this research was provided by:
Fraunhofer Cluster of Excellence Immune-Mediated Diseases
Deutsche Forschungsgemeinschaft (437531118)
Medizinische Hochschule Hannover (MHH)
Article History
Received: 9 February 2024
Accepted: 19 June 2024
First Online: 16 July 2024
Competing interests
: T.T. is founder and CSO/CMO of Cardior Pharmaceuticals GmbH, a wholly-owned subsidiary of Novo Nordisk A/S (outside of the content of this manuscript). All other authors have no conflict of interest.